Yonathan Hasin
Impact in
-
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Cardiac pacing and defibrillation studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Surgery top 2%
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
Papers in
-
- Acute Myocardial Infarction Research 26
- Cardiac electrophysiology and arrhythmias 11
- Heart Failure Treatment and Management 10
- Viral Infections and Immunology Research 3
- Surgery 38
- Coronary Interventions and Diagnostics 25
- Lipoproteins and Cardiovascular Health 7
- Co-authors
- Morris Mosseri (34 shared papers)Mervyn S. Gotsman (56 shared papers)Chaim Lotan (34 shared papers)M S Gotsman (4 shared papers)R. Yarom (2 shared papers)Yoseph Rozenman (24 shared papers)Allan S. Jaffe (5 shared papers)Kristian A. Thygesen (5 shared papers)
- Journals
- The American Journal of Cardiology (15 papers)European Heart Journal (12 papers)Journal of Molecular and Cellular Cardiology (9 papers)Clinical Cardiology (9 papers)Cardiology (8 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Yonathan Hasin
160 papers receiving 10.7k citations
Yonathan Hasin's Hit Papers
Peers
Comparison fields: 5 of 113
- Cardiology and Cardiovascular Medicine 5.5k
- Surgery 967
- Complementary and alternative medicine 129
- Genetics 143
- Radiology, Nuclear Medicine and Imaging 272
Countries citing papers authored by Yonathan Hasin
This map shows the geographic impact of Yonathan Hasin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonathan Hasin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonathan Hasin more than expected).
Fields of papers citing papers by Yonathan Hasin
This network shows the impact of papers produced by Yonathan Hasin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonathan Hasin. The network helps show where Yonathan Hasin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yonathan Hasin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 Hit paper breakdown → | 2008 | 2945 |
| 2 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Hit paper breakdown → | 2008 | 2240 |
| 3 | How to use high-sensitivity cardiac troponins in acute cardiac care Hit paper breakdown → | 2012 | 652 |
| 4 | 2010 | 509 | |
| 5 | Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Hit paper breakdown → | 1986 | 369 |
| 6 | 1985 | 304 | |
| 7 | 2008 | 272 | |
| 8 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 244 |
| 9 | 2011 | 226 | |
| 10 | 2001 | 171 | |
| 11 | 1995 | 148 | |
| 12 | 1990 | 138 | |
| 13 | 2000 | 127 | |
| 14 | Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol Hit paper breakdown → | 2021 | 116 |
| 15 | 1997 | 100 | |
| 16 | 2005 | 91 | |
| 17 | 2007 | 90 | |
| 18 | [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. | 2005 | 87 |
| 19 | 1985 | 81 | |
| 20 | 1993 | 81 |
About Yonathan Hasin
Yonathan Hasin is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Pathology and Forensic Medicine, Emergency Medicine and Genetics, having authored 171 papers that have together received 11.5k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (26 papers), Coronary Interventions and Diagnostics (25 papers), Cardiac electrophysiology and arrhythmias (11 papers), Heart Failure Treatment and Management (10 papers), Lipoproteins and Cardiovascular Health (7 papers), Cardiac Ischemia and Reperfusion (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Viral Infections and Immunology Research (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.5k citations), Surgery (967 citations), Complementary and alternative medicine (129 citations), Genetics (143 citations) and Radiology, Nuclear Medicine and Imaging (272 citations). Yonathan Hasin has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Morris Mosseri, Mervyn S. Gotsman, Chaim Lotan, M S Gotsman, R. Yarom, Yoseph Rozenman, Allan S. Jaffe, Kristian A. Thygesen, Marco Tubaro U and Mario Plebani. Their work appears in journals such as The American Journal of Cardiology, European Heart Journal, Journal of Molecular and Cellular Cardiology, Clinical Cardiology and Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.